Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.

Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.

Journal article

Adetifa IMO. et al, (2021), Nature communications, 12

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera

Journal article

Zhou D. et al, (2021), Cell, 184, 2348 - 2361.e6

A booster dose enhances immunogenicity of the COVID-19 vaccine candidate ChAdOx1 nCoV-19 in aged mice

Journal article

Silva-Cayetano A. et al, (2021), Med, 2, 243 - 262.e8

Publisher Correction: ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques

Journal article

van Doremalen N. et al, (2021), Nature, 590, E24 - E24

Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors.

Journal article

Uyoga S. et al, (2021), Science (New York, N.Y.), 371, 79 - 82

ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques

Journal article

van Doremalen N. et al, (2020), Nature, 586, 578 - 582

Load More